omeprazole has been approved by the food and drug administration for short-term therapy of severe erosive esophagitis , poorly responsive symptomatic gastroesophageal reflux disease , and long-term management of zollinger-ellison syndrome .
C0028978
omeprazole
C0043515
zollinger-ellison syndrome